These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 18075823

  • 21. Low-dose aspirin has no impact on systemic level of serine protease inhibitors in healthy volunteers.
    Wex T, Treiber G, Link A, Wex H, Malfertheiner P.
    Transl Res; 2009 Jun; 153(6):272-4. PubMed ID: 19446280
    [Abstract] [Full Text] [Related]

  • 22. Temporal induction of secretory leukocyte protease inhibitor (SLPI) in odontoblasts by lipopolysaccharide and wound infection.
    Choi BD, Jeong SJ, Wang G, Kim HJ, Kim BO, Hwang HK, Lim DS, Kim SH, Jeong MJ.
    J Endod; 2009 Jul; 35(7):997-1002. PubMed ID: 19567322
    [Abstract] [Full Text] [Related]

  • 23. Toll-like receptors: their roles in bacterial recognition and respiratory infections.
    Randhawa AK, Hawn TR.
    Expert Rev Anti Infect Ther; 2008 Aug; 6(4):479-95. PubMed ID: 18662115
    [Abstract] [Full Text] [Related]

  • 24. Pulmonary defense mechanisms against pneumonia and sepsis.
    Tsai KS, Grayson MH.
    Curr Opin Pulm Med; 2008 May; 14(3):260-5. PubMed ID: 18427251
    [Abstract] [Full Text] [Related]

  • 25. Identification of a kazal-type serine protease inhibitor with potent anti-staphylococcal activity as part of Hydra's innate immune system.
    Augustin R, Siebert S, Bosch TC.
    Dev Comp Immunol; 2009 Jul; 33(7):830-7. PubMed ID: 19428484
    [Abstract] [Full Text] [Related]

  • 26. Elastolytic proteases: inflammation resolution and dysregulation in chronic infective lung disease.
    Taggart CC, Greene CM, Carroll TP, O'Neill SJ, McElvaney NG.
    Am J Respir Crit Care Med; 2005 May 15; 171(10):1070-6. PubMed ID: 15695494
    [No Abstract] [Full Text] [Related]

  • 27. [Toll-like receptor in lung response to pathogens].
    Rivas-Santiago B, Juárez E.
    Rev Invest Clin; 2007 May 15; 59(6):481-8. PubMed ID: 18402340
    [Abstract] [Full Text] [Related]

  • 28. Downregulation of secretory leukocyte proteinase inhibitor in chronic obstructive lung disease: the role of TGF-beta/Smads signaling pathways.
    Luo BL, Niu RC, Feng JT, Hu CP, Xie XY, Ma LJ.
    Arch Med Res; 2008 May 15; 39(4):388-96. PubMed ID: 18375249
    [Abstract] [Full Text] [Related]

  • 29. Pulmonary infections in the adolescent with immunodeficiency.
    Abuhammour W, Kumar A, Patterson MJ.
    Adolesc Med; 2000 Oct 15; 11(3):663-80. PubMed ID: 11060561
    [Abstract] [Full Text] [Related]

  • 30. Secretory leukocyte protease inhibitor is an inducible antimicrobial peptide expressed in Staphylococcus aureus endophthalmitis.
    Reviglio VE, Sambuelli RH, Olmedo A, Falco M, Echenique J, O'Brien TP, Kuo IC.
    Mediators Inflamm; 2007 Oct 15; 2007():93857. PubMed ID: 18274645
    [Abstract] [Full Text] [Related]

  • 31. The secretory leukocyte protease inhibitor (SLPI) and the secondary granule protein lactoferrin are synthesized in myelocytes, colocalize in subcellular fractions of neutrophils, and are coreleased by activated neutrophils.
    Jacobsen LC, Sørensen OE, Cowland JB, Borregaard N, Theilgaard-Mönch K.
    J Leukoc Biol; 2008 May 15; 83(5):1155-64. PubMed ID: 18285402
    [Abstract] [Full Text] [Related]

  • 32. Cleaved secretory leucocyte protease inhibitor as a biomarker of chymase activity in allergic airway disease.
    Belkowski SM, Boot JD, Mascelli MA, Diamant Z, de Garavilla L, Hertzog B, Polkovitch D, Towers M, Batheja A, D'Andrea MR.
    Clin Exp Allergy; 2009 Aug 15; 39(8):1179-86. PubMed ID: 19400896
    [Abstract] [Full Text] [Related]

  • 33. Expression of secretory leukocyte proteinase inhibitor in the submandibular glands of AIDS patients.
    Rocha LA, Vargas PA, Silva LF, Leon JE, Santos AB, Hiemstra PS, Mauad T.
    Oral Dis; 2008 Jan 15; 14(1):82-8. PubMed ID: 18173453
    [Abstract] [Full Text] [Related]

  • 34. Role of host defense peptides of the innate immune response in sepsis.
    Hirsch T, Metzig M, Niederbichler A, Steinau HU, Eriksson E, Steinstraesser L.
    Shock; 2008 Aug 15; 30(2):117-26. PubMed ID: 18091568
    [Abstract] [Full Text] [Related]

  • 35. Secretory Leucoprotease Inhibitor (SLPI) Promotes Survival during Acute Pseudomonas aeruginosa Infection by Suppression of Inflammation Rather Than Microbial Killing.
    Osbourn M, Rodgers AM, Dubois AV, Small DM, Humphries F, Delagic N, Moynagh PN, Weldon S, Taggart CC, Ingram RJ.
    Biomolecules; 2022 Nov 22; 12(12):. PubMed ID: 36551159
    [Abstract] [Full Text] [Related]

  • 36. Mucociliary clearance--a critical upper airway host defense mechanism and methods of assessment.
    Antunes MB, Cohen NA.
    Curr Opin Allergy Clin Immunol; 2007 Feb 22; 7(1):5-10. PubMed ID: 17218804
    [Abstract] [Full Text] [Related]

  • 37. [Influence of microwave magnetoresonance therapy on various parameters of local immune defence in the respiratory tract in ailing children].
    Uzunova AN, Kurilova EV, Darovskikh SN.
    Vopr Kurortol Fizioter Lech Fiz Kult; 2004 Feb 22; (6):27-9. PubMed ID: 15717536
    [Abstract] [Full Text] [Related]

  • 38. Cleaved SLPI, a novel biomarker of chymase activity.
    Belkowski SM, Masucci J, Mahan A, Kervinen J, Olson M, de Garavilla L, D'Andrea MR.
    Biol Chem; 2008 Sep 22; 389(9):1219-24. PubMed ID: 18713008
    [Abstract] [Full Text] [Related]

  • 39. WFDC2 (HE4): a potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung.
    Bingle L, Cross SS, High AS, Wallace WA, Rassl D, Yuan G, Hellstrom I, Campos MA, Bingle CD.
    Respir Res; 2006 Apr 06; 7(1):61. PubMed ID: 16600032
    [Abstract] [Full Text] [Related]

  • 40. [Potential of novel antimycobacterial immune factors, SLPI and lipocalin 2].
    Saiga H, Takeda K.
    Kekkaku; 2010 Jun 06; 85(6):523-30. PubMed ID: 20662248
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.